CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy.
Prince HM, Wall D, Rischin D, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Wolf M, Januszewicz EH, Westerman D, Richardson G, Scarlett J, Briggs P.
Prince HM, et al. Among authors: seymour jf.
Cytotherapy. 2002;4(2):147-55. doi: 10.1080/146532402317381857.
Cytotherapy. 2002.
PMID: 12006210
Clinical Trial.